日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122

KEYNOTE-122研究中,对复发/转移性鼻咽癌患者血浆中Epstein-Barr病毒DNA的分析以及帕博利珠单抗或化疗的临床疗效

Chan, Anthony T C; Lee, Victor Ho Fun; Hong, Ruey-Long; Ahn, Myung-Ju; Chong, Wan Qin; Spreafico, Anna; Kim, Sung-Bae; Ho, Gwo Fuang; Caguioa, Priscilla B; Ngamphaiboon, Nuttapong; Swaby, Ramona F; Wei, Bo; Webber, Andrea L; Kang, John; Gumuscu, Burak; Yuan, Jianda; Siu, Lillian L

Application of radiomics in lung immuno-oncology

放射组学在肺部免疫肿瘤学中的应用

Yan, Weisi; Quan, Chen; Mourad, Waleed F; Yuan, Jianda; Shi, Zheng; Yang, Jun; Lu, Qiuxia; Zhang, Jie

Hallmarks of Resistance to Immune-Checkpoint Inhibitors

免疫检查点抑制剂耐药性的标志

Karasarides, Maria; Cogdill, Alexandria P; Robbins, Paul B; Bowden, Michaela; Burton, Elizabeth M; Butterfield, Lisa H; Cesano, Alessandra; Hammer, Christian; Haymaker, Cara L; Horak, Christine E; McGee, Heather M; Monette, Anne; Rudqvist, Nils-Petter; Spencer, Christine N; Sweis, Randy F; Vincent, Benjamin G; Wennerberg, Erik; Yuan, Jianda; Zappasodi, Roberta; Lucey, Vanessa M Hubbard; Wells, Daniel K; LaVallee, Theresa

Absolute lymphocyte count as a prognostic biomarker for overall survival in patients with advanced melanoma treated with ipilimumab

绝对淋巴细胞计数作为接受伊匹木单抗治疗的晚期黑色素瘤患者总生存期的预后生物标志物

Postow, Michael A; Chasalow, Scott D; Kuk, Deborah; Panageas, Katherine S; Cheng, Michael L; Yuan, Jianda; Wolchok, Jedd D

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade.

局部化疗和 CTLA-4 阻断可产生强大的抗肿瘤反应

Ariyan Charlotte E, Brady Mary Sue, Siegelbaum Robert H, Hu Jian, Bello Danielle M, Rand Jamie, Fisher Charles, Lefkowitz Robert A, Panageas Kathleen S, Pulitzer Melissa, Vignali Marissa, Emerson Ryan, Tipton Christopher, Robins Harlan, Merghoub Taha, Yuan Jianda, Jungbluth Achim, Blando Jorge, Sharma Padmanee, Rudensky Alexander Y, Wolchok Jedd D, Allison James P

Immunotherapy biomarkers 2016: overcoming the barriers

2016年免疫疗法生物标志物:克服障碍

Gulley, James L; Berzofsky, Jay A; Butler, Marcus O; Cesano, Alessandra; Fox, Bernard A; Gnjatic, Sacha; Janetzki, Sylvia; Kalavar, Shyam; Karanikas, Vaios; Khleif, Samir N; Kirsch, Ilan; Lee, Peter P; Maccalli, Cristina; Maecker, Holden; Schlom, Jeffrey; Seliger, Barbara; Siebert, Janet; Stroncek, David F; Thurin, Magdalena; Yuan, Jianda; Butterfield, Lisa H

Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients

外周CD8效应记忆1型T细胞与接受伊匹木单抗治疗的IV期黑色素瘤患者的预后相关

Wistuba-Hamprecht, Kilian; Martens, Alexander; Heubach, Florian; Romano, Emanuela; Geukes Foppen, Marnix; Yuan, Jianda; Postow, Michael; Wong, Phillip; Mallardo, Domenico; Schilling, Bastian; Di Giacomo, Anna Maria; Khammari, Amir; Dreno, Brigitte; Maio, Michele; Schadendorf, Dirk; Ascierto, Paolo A; Wolchok, Jedd D; Blank, Christian U; Garbe, Claus; Pawelec, Graham; Weide, Benjamin

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

PD-1/PD-L1免疫检查点阻断疗法转化生物标志物研究的现状与展望

Ma, Weijie; Gilligan, Barbara M; Yuan, Jianda; Li, Tianhong

Immune Monitoring Technology Primer: protein microarray ('seromics')

免疫监测技术入门:蛋白质微阵列(“血清组学”)

Yuan, Jianda; Wang, Ena; Fox, Bernard A

Circulating protein and antibody biomarker for personalized cancer immunotherapy

用于个体化癌症免疫治疗的循环蛋白和抗体生物标志物

Yuan, Jianda